Article

Insulin--a growth hormone.

Endocrinology and Diabetes Research Unit, Schneider Children's Medical Center of Israel, WHO Collaborating Center for the Study of Diabetes in Youth, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel.
Archives of Physiology and Biochemistry 03/2008; 114(1):11-6. DOI: 10.1080/13813450801928356
Source: PubMed

ABSTRACT Insulin is a peptide hormone with a high degree of homology with the insulin-like growth factor I (IGF-I). Its biological actions are interlaced with those of GH and IGF-I. The objective of this study is to review the growth promoting actions of insulin. The experimental evidence consists of the use of organ cultures of neonatal mice condilar cartilage insulin which stimulates the cartilage cell differentiation and maturation. Injection of insulin to hypohysectomized rats stimulated tibial growth. Clinical evidence is manifold. Babies with diabetes and hypoinsulinemia are short, whereas babies with hyperinsulinism are big. Children with idiopathic short stature have low insulin whereas obese children with hyperinsulinism are tall. Hypo-insulinized children with diabetes slow their growth until the insulin dose is optimized. It remains to be clarified whether insulin exerts its growth promoting actions via its own receptors, via the IGF-I receptors, or via a hybrid (insulin--IGF-I) receptor.

0 Bookmarks
 · 
104 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Insulin is a peptide hormone with a high degree of homology with the insulin-like growth factor I (IGF-I). Its biological actions are interlaced with those of GH and IGF-I. The objective of this study is to review the growth promoting actions of insulin. The experimental evidence consists of the use of organ cultures of neonatal mice condilar cartilage insulin which stimulates the cartilage cell differentiation and maturation. Injection of insulin to hypohysectomized rats stimulated tibial growth. Clinical evidence is manifold. Babies with diabetes and hypoinsulinemia are short, whereas babies with hyperinsulinism are big. Children with idiopathic short stature have low insulin whereas obese children with hyperinsulinism are tall. Hypo-insulinized children with diabetes slow their growth until the insulin dose is optimized. It remains to be clarified whether insulin exerts its growth promoting actions via its own receptors, via the IGF-I receptors, or via a hybrid (insulin – IGF-I) receptor.
    Archives of Physiology and Biochemistry. 10/2008; 114(1).
  • [Show abstract] [Hide abstract]
    ABSTRACT: The following is an account of investigations carried out at the Paediatric Department, University Hospital of Lund on the treatment of juvenile diabetes with the Lente Insulins.The material comprises 42 patients, aged 2–17 years. In 37 cases (i.e. 88 per cent) a A blood sugar below 150 mg/100 ml was obtained. During establishment on the Lente Insulins we noted in some cases a substantial increase in height. Insulin reactions were rare and most patients felt better after changing to Lente Insulin.L'insuline « lente » dans le traitement du diabète juvénile.Résultats obtenus avec l'insuline « lente » dans le traitement de cas de diabète juvénile. Quarante-deux patients âgées de 2 à 17 ans ont été traités. Dans 37 cas (soit 88%), le taux de la glycémie put être ramené en dessous de 150 mg/100 cm3. Une augmentation notable de la croissance en hauteur a été observée dans certains cas durant le traitement par l'insuline « lente ». Les réactions d.'intolérance à l'insuline furent rares et la plupart des malades se sentirent mieux après le passage à l'insuline « lente ».“Lente”-Insulinpräparate bei jugendlichem Diabetes.Bericht über die Behandlung von jugendlichem Diabetes mellitus mit “Lente” Insulinpräparaten. 42 Kranke im Alter von 2–17 Jahren wurden auf diese Weise behandelt. In 37 Fällen, d.i. bei 88%, wurde ein Blutzuckerspiegel von unter 150 mg/100 ml erreicht. Während der Behandlung mit “Lente” Insulin kam es bei manchen Fallen zu einer wesentlichen Zunahme im Körperwuchs. Insulinreaktionen waren selten und die Mehrzahl der Patienten wies eine Besserung im Allgemeinbefinden auf, wenn sie auf “Lente” Insulinpräparate umgestellt wurden.Insulinas «Lentet» en la diabetes infantil.Se expone el tratamiento de la diabetes mellitus infantil con insulinas «Lente». Fueron tratados cuarenta y dos pacientes de 2 a 17 años de edad. En 37 easos (es decir el 88%) se obtuvo un delta de azúcar en la sangre inferior a 150 mg por 100 ml. Durante el tratamiento practicado con insulinas «Lente», se observó un aumento apreciable de la estatura en algunos casos. Se produjeron rara vez reacciones insulínicas y la mayoría de los pacientes se sintió mejor después de cambiar con las insulinas «Lente».
    Acta Paediatrica 05/1957; 46(3). · 1.97 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT Objective: One of the factors preventing clinical application of regenerative medicine to degenerative cartilage diseases is a suitable source of cells. Chondrocytes, the only cell type of cartilage, grown in vitro under culture conditions to expand cell numbers lose their phenotype along with the ability to generate hyaline cartilaginous tissue. In this study we determine that a serum- and growth factor- free 3D culture system restores the ability of the passaged chondrocytes to form cartilage tissue in vitro, a process that involves sox 9. Methods: Bovine articular chondrocytes (BAC) were passaged twice to allow for cell number expansion (P2) and cultured at high density on 3D collagen type II-coated membranes in media supplemented with insulin, high glucose, and dexamethasone (SF3D). The cells were characterized after monolayer expansion and following 3D culture by flow cytometry, gene expression, and histology. The early changes in signalling transduction pathways during redifferentiation were characterized. Results: The P2 cells showed a progenitor-like antigen profile of 99% CD44+ and 40% CD105+ and a gene expression profile suggestive of interzone cells. P2 in SF3D expressed chondrogenic genes and accumulated extracellular matrix (ECM). Down-regulating insulin receptor (IR) with HNMPA-(AM3) or the PI-3/AKT kinase pathway (activated by insulin treatment) with wortmannin inhibited collagen synthesis. HNMPA-(AM3) reduced expression of Col2 , Colx1, IR and IGF1R genes as well as Sox 6 and 9. Co-IP and ChIP analysis of HNMPA-(AM3) treated cells showed binding of the co-activators Sox6 and Med12 with Sox9 but reduced Sox9-Col2a1 binding. Conclusions: We describe a novel culture method which allows for increase in the number of chondrocytes and promotes hyaline-like cartilage tissue formation in part by insulin mediated Sox9-Col2a1 binding. The suitability of the tissue generated via this approach for use in joint repair needs to be examined in vivo. Key words: Cartilage tissue regeneration, re-differentiation, serum free, insulin, chondrocytes.
    Tissue Engineering Part A 03/2014; · 4.64 Impact Factor

Full-text

Download
1 Download
Available from